Oncology
Elizabeth Mittendorf, M.D.
Professor of Surgery at Harvard Medical School; Robert and Karen Hale Endowed Chair in Surgical Oncology at Brigham and Women's Hospital; Chief of Division of Breast Surgery at Beth Israel Deaconess Medical Center; Co-Leader of the Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute; Co-Leader of the Breast Program for the Dana-Farber/Harvard Cancer Center; President-elect of the American Society of Clinical Oncology (ASCO) 2026-2027
Dr. Elizabeth Mittendorf is an internationally recognized breast surgeon and pioneering immunotherapy researcher specializing in early-stage and metastatic breast cancer, particularly triple-negative disease. As Chief of the Division of Breast Surgery and a Professor of Surgery at Harvard Medical School, she leads clinical and laboratory efforts focused on cancer immunotherapy and biomarker identification. Her research investigates how preoperative immunotherapy combined with chemotherapy affect
30+
Years in Practice
Credentials
Board Certifications
- Surgery (American Board of Surgery)
Education & Training
- Case Western Reserve University School of Medicine — M.D.
- Case Western Reserve University — Residency in General Surgery
- University of Texas MD Anderson Cancer Center — Fellowship in Surgical Oncology
- University of Texas Graduate School of Biomedical Sciences at Houston — Ph.D. in Immunology
Peer Recognition
- Castle Connolly — Top Doctor
2022-2026 (5 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
- Beth Israel Deaconess Medical Center
- Harvard Medical Faculty Physicians
Languages
English
Experience
30+ years in practice